hES Cell and Global Market Projections
The worldwide market for hESCs is estimated at US$3.8 B in 2010. Growing at a robust CAGR of 24.8% during the period 2007-2015, the market is projected to reach US$10.7 B by 2015. While the global stem cell market is estimated to be $88.3 B by 2014, growing at a CAGR of 14.8 % from 2009 to 2014.
While the global stem cell market is estimated to be $88.3 B by 2014, growing at a CAGR of 14.8 % from 2009 to 2014. The US currently holds a 60% share of the global stem cell market and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells.
The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies.
- Embryonic stem cell (hESC) research has attracted a lot of attention the world over and the controversy surrounding it just does not seem to die down;
- The benefits of stem cell therapy are attracting an increasing number of patients;
- The product submarket for human and embryo stem cells are expected to drive the growth of the overall market;
- Intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment;
- However, the high cost of the therapy may affect market growth.
Categories: Stem Cell Technology
